Review summarizes the potential of thyroid artery embolization to treat benign thyroid hyperplasia, indicating a promising alternative for patients declining surgery.
Thyroid artery embolization (TAE) is emerging as a potential minimally invasive therapy for benign thyroid hyperplasia (BTH), including multinodular goiter and Graves’ disease, particularly for patients who are poor surgical candidates or who decline surgery. This review summarizes contemporary evidence, technical practices, and areas of consensus and heterogeneity in this technique.
No takes yet. Share an insight, caveat, or question.
Sag et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: